76 results on '"Bystryn, Jean-Claude"'
Search Results
2. Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies
3. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis
4. Effect of Intravenous Immunoglobulin Therapy on Serum Levels of IgG1 and IgG4 Antidesmoglein 1 and Antidesmoglein 3 Antibodies in Pemphigus Vulgaris
5. Comparative Effectiveness of Azathioprine or Mycophenolate Mofetil as an Adjuvant for the Treatment of Bullous Pemphigoid
6. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
7. Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus
8. Kinetics of Response to Conventional Treatment in Patients With Pemphigus Vulgaris
9. Improvement of Intravenous Immunoglobulin Therapy for Bullous Pemphigoid by Adding Immunosuppressive Agents: Marked Improvement in Depletion of Circulating Autoantibodies
10. Does imiquimod work in infantile hemangiomas?
11. Frequency of Shifts Over Time in the Profile of Antidesmoglein Antibodies in Pemphigus Vulgaris
12. A Confusing Message Will Not Improve the Detection of Melanoma
13. Increasing Ratio of Thin to Thick Melanoma Lesions: Pathogenesis and Early Detection of This Cancer
14. Keratin intermediate filament retraction is linked to plakoglobin-dependent signaling in pemphigus vulgaris
15. Sensitivity of indirect immunofluorescence and ELISA in detecting intercellular antibodies in endemic pemphigus foliaceus (Fogo Selvagem)
16. Cutaneous pemphigus vulgaris: What causes it?
17. Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: A potential marker of response to immunotherapy?
18. Circulating Tumor Cells and Detection of the Melanoma-Associated Antigen HMW-MAA in the Serum of Melanoma Patients
19. A novel explanation for acantholysis in pemphigus vulgaris: The basal cell shrinkage hypothesis
20. Why Is the Mortality of Bullous Pemphigoid Greater in Europe than in the US?
21. MELANOMA VACCINES: A REVIEW OF CURRENT CLINICAL TRIALS: P2208
22. Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy
23. Tumid Lupus Erythematosus: Criteria for Classification With Immunohistochemical Analysis
24. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris
25. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris
26. Improved Identification of Potentially Dangerous Pigmented Skin Lesions by Computerized Image Analysis
27. Can Nondermatologists Really Recognize Potentially Dangerous Skin Lesions as Well as Dermatologists?
28. Treatment of pemphigus with intravenous immunoglobulin
29. Limitations in Enzyme-linked Immunosorbent Assays for Antibodies Against Desmogleins 1 and 3 in Patients With Pemphigus
30. Oral and Topical Corticosteroids in Bullous Pemphigoid
31. Laryngeal and nasal involvement in pemphigus vulgaris
32. Cyclosporine Therapy Should Be Considered for Maintenance of Remission in Patients With Pemphigus
33. Epiluminescence Microscopy: A Reevaluation of Its Purpose
34. An Alternate Explanation for the Increase in the Incidence of Melanoma Being Restricted to Patients With Thin Lesions
35. Ineffectiveness of Cyclosporine as an Adjuvant to Corticosteroids in the Treatment of Pemphigus
36. The Problems with Punitive Damages in Lawsuits against Managed-Care Organizations
37. Relation Between Skin Temperature and Location of Facial Lesions in Seborrheic Dermatitis
38. Expression of SS-A/Ro and SS-B/La Antigens in Skin Biopsy Specimens of Patients With Photosensitive Forms of Lupus Erythematosus
39. Reimbursement for Evaluation and Management Services
40. Methotrexate as an Adjuvant Treatment for Pemphigus Vulgaris
41. Is Mycophenolic Acid Effective for the Treatment of Pemphigus?
42. Vitiligo Antibodies Are Not Directed to Tyrosinase
43. Sensitivity of indirect immunofluorescence and immunoblotting for the detection of intercellular antibodies in endemic pemphigus foliaceus (fogo selvagem)
44. Bullous pemphigoid in a 2-month-old infant
45. CDKN2A Mutations in Multiple Primary Melanomas
46. Oral Psoralen With UV-A Therapy Releases Circulating Growth Factor(s) That Stimulates Cell Proliferation
47. Simultaneous occurrence of herpetiform pemphigus and endemic pemphigus foliaceus (fogo selvagem)
48. Autoantibodies to Hair Follicles in C3H/HeJ Mice With Alopecia Areata-Like Hair Loss
49. Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus
50. Commentary
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.